Olawunmi Oyedeji | Oncology | Innovative Research Award

Innovative Research Award

Olawunmi Oyedeji
The Christie NHS Foundation Trust

                          Olawunmi Oyedeji
Affiliation The Christie NHS Foundation Trust
Country United Kingdom
Scopus ID 58803277000
Documents 2
Citations 2
h-index 2
Subject Area Oncology
Event Global Diseases Research Awards
ORCID 0009-0008-0626-3422

Olawunmi Oyedeji is a researcher affiliated with The Christie NHS Foundation Trust, United Kingdom, whose academic activities contribute to the field of oncology research. The Innovative Research Award recognizes researchers demonstrating valuable contributions through scientific investigation, clinical advancement, and knowledge development within their respective disciplines. [1]

Abstract

The Innovative Research Award highlights academic excellence and meaningful contributions in oncology research. Olawunmi Oyedeji, affiliated with The Christie NHS Foundation Trust, United Kingdom, represents emerging research activities focused on advancing healthcare knowledge and improving scientific understanding. With documented publications, citations, and research engagement indexed through Scopus, the researcher demonstrates participation in scholarly communication. The award recognizes dedication toward innovative approaches, evidence-based practices, and contributions supporting progress in global disease research and clinical advancement. [1]

Keywords

Oncology Research, Clinical Research, Innovative Research Award, Cancer Research, Healthcare Innovation

Introduction

Oncology research plays an important role in understanding cancer biology, improving diagnosis, and developing effective therapeutic strategies. Researchers working within clinical and academic institutions contribute essential evidence that supports improvements in patient care and healthcare systems. [2]

Research Profile

Olawunmi Oyedeji is associated with The Christie NHS Foundation Trust, a leading healthcare institution in the United Kingdom. The research profile includes two indexed documents, two citations, and an h-index of two according to available Scopus information. [1]

Research Contributions

The researcher’s contributions are positioned within oncology and healthcare research. Scientific contributions in this area support better understanding of diseases, treatment approaches, clinical methodologies, and evidence-based medical practices. Such efforts strengthen collaborative research environments and promote advancement in cancer-related knowledge. [2]

Publications

The researcher has published scholarly documents indexed within Scopus databases. These publications contribute to academic discussions in oncology and related healthcare disciplines. Research outputs provide opportunities for knowledge exchange and future scientific collaboration among international researchers. [3]

Research Impact

Research impact is reflected through scholarly visibility, citation activity, and contribution to scientific literature. The available metrics indicate participation in academic research communication and demonstrate the importance of continued investigation within oncology and clinical sciences. [4]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate commitment toward scientific advancement and meaningful research activities. Based on the researcher’s oncology-focused profile, institutional affiliation, and academic contributions, Olawunmi Oyedeji represents a suitable candidate for recognition within the Global Diseases Research Awards framework. [4]

Conclusion

Olawunmi Oyedeji’s research profile demonstrates involvement in oncology-related scientific activities through institutional association, publications, and academic indexing. The Innovative Research Award acknowledges continued efforts toward research development and contributions supporting healthcare innovation and global scientific progress.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Olawunmi Oyedeji, Author ID 58803277000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58803277000
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Information.
    https://globaldiseases.org/
  3. Oisakede, E. O., Oyedeji, O. O., Olawuyi, O. F., Alabi, J. O., Daniel, R. I. A., & Olawade, D. B. (2026). Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment. Nano TransMed, 5, Article 100113.
    https://doi.org/10.1016/j.ntm.2026.100113
  4. Oyedeji, O. O., & Oisakede, E. O. (2026). Radiation-induced rhinosinusitis after treatment of nasopharyngeal and selected sinonasal cancers: A narrative review. Sinusitis, 10(1), Article 100015.
    https://doi.org/10.3390/sinusitis10010015

Branko Dujovic | Dermatoncology | Innovative Research Award

Innovative Research Award

Researcher Information
Affiliation Military Medical Academy
Country Serbia
Scopus ID 58245030500
Documents 6
Citations 21
h-index 2
Subject Area Dermatoncology
Event Global Diseases Research Awards
ORCID 0009-0009-1497-5777

Branko Dujovic of the Military Medical Academy, Serbia, is recognized for his contributions to medical research, with a particular focus on dermatoncology. The Innovative Research Award highlights his scholarly excellence, scientific integrity, and meaningful impact on advancing clinical science. Through his published research, interdisciplinary collaboration, and commitment to evidence-based medical investigation, he has built a strong academic profile. His work emphasizes improvements in disease diagnosis, evaluation of treatment strategies, and enhancement of patient-centered healthcare outcomes, reflecting a consistent dedication to advancing knowledge and strengthening modern clinical practice in oncology and dermatology-related research.

Abstract

Branko Dujovic is a researcher affiliated with the Military Medical Academy in Serbia whose scholarly activities contribute to the field of dermatoncology. Through peer-reviewed publications, clinical investigations, and collaborative research efforts, he has supported the advancement of scientific understanding related to skin cancer and associated diseases. His academic record, including indexed publications, citations, and international researcher identifiers, demonstrates engagement with contemporary medical science. The Innovative Research Award acknowledges researchers whose work promotes scientific progress, encourages evidence-based practice, and contributes to improving healthcare knowledge through responsible and impactful research activities.[1]

Keywords

Dermatoncology, Clinical Research, Medical Science, Skin Cancer Research, Academic Excellence, Innovative Research Award, Healthcare Innovation, Disease Investigation, Scientific Publications, Global Diseases Research Awards.

Introduction

Dermatoncology represents a specialized area of medicine focused on understanding, diagnosing, and managing skin-related cancers. Researchers working within this discipline contribute valuable evidence supporting clinical decision-making and patient care improvements. Branko Dujovic has participated in research activities that align with these objectives and support ongoing scientific advancement within the medical community.[1]

Research Profile

Affiliated with the Military Medical Academy, Branko Dujovic maintains an academic profile indexed within international scholarly databases. His publication record includes research outputs relevant to dermatoncology and related medical disciplines. The available metrics indicate active participation in scientific communication and engagement with peer-reviewed research environments.[4]

Research Contributions

The research contributions of Branko Dujovic are associated with clinical and scientific investigations addressing disease mechanisms, patient outcomes, and healthcare practices. His studies support the broader body of medical knowledge by providing data-driven insights that may assist clinicians, researchers, and healthcare institutions in understanding dermatological oncology challenges.[2]

Publications

The researcher has produced six indexed documents that collectively contribute to scholarly discussion within his field. These publications demonstrate participation in scientific dissemination and provide evidence of sustained academic activity. Published work remains an important indicator of research productivity, professional collaboration, and contribution to medical literature.

Research Impact

Citation metrics indicate that the researcher’s publications have been referenced by other scholars, reflecting engagement within the scientific community. While quantitative indicators provide only one measure of influence, citations and indexing demonstrate the visibility of research outputs and their relevance to ongoing academic discussions.[1]

Award Suitability

Branko Dujovic demonstrates characteristics associated with the objectives of the Innovative Research Award, including scholarly productivity, scientific engagement, and commitment to advancing medical knowledge. His documented research activities, institutional affiliation, and contributions to dermatoncology support consideration for recognition within the Global Diseases Research Awards program.[3]

Conclusion

The academic profile of Branko Dujovic reflects participation in meaningful scientific research within dermatoncology. Through publications, citation impact, and professional engagement, he contributes to the advancement of healthcare knowledge. Recognition through the Innovative Research Award highlights the value of continued research efforts that support evidence-based medicine and scientific progress.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Branko Dujovic, Author ID 58245030500. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=58245030500
  2. ORCID. (n.d.). Researcher profile and scholarly identifier for Branko Dujovic
    .
    https://orcid.org/0009-0009-1497-5777
  3. Global Diseases Research Awards. (n.d.). Innovative Research Award and recognition framework.
    https://globaldiseases.org/
  4. Dujovic, B., Popovic, A., Jalovcic Suljevic, A., Cikota-Aleksic, B., Balic, M., Salatic, I., Pavlica, J., Schnecko, P., Mesti, T., Terzo, M., Bicakcic Filipovic, E., & Kandolf, L. (2026). Prognostic significance of inflammatory biomarkers in first-line immunotherapy for metastatic melanoma: Multicentric study (Version 1). Preprints.org.
    https://doi.org/10.20944/preprints202604.1631.v1
  5. Torres-Zurita, A., Vázquez-Montero, L., Gallego-López, L., Mediano-Rambla, M. D., & de la Cruz-Merino, L. (2023). Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: A case report. Frontiers in Immunology, 14, 1150128.
    https://doi.org/10.3389/fimmu.2023.1150128

Nazlı Erdoğdu | Cancer | Research Excellence Award

Assoc. Prof. Dr. Nazlı Erdoğdu | Cancer | Research Excellence Award

Hacettepe University | Turkey

Assoc. Prof. Dr. Nazlı Erdoğdu is an academic researcher at Hacettepe University, Ankara, Turkey, with recognized expertise in pharmaceutical nanotechnology, dermal and transdermal drug delivery systems, and advanced topical formulations. Her research focuses on the design and evaluation of nanoparticle-based delivery platforms, including polymeric nanoparticles and chitosan-based systems, aimed at improving therapeutic efficacy and safety for dermatological and oncological applications. She has authored 23 Scopus-indexed publications, which have received over 538 citations, reflecting the relevance and impact of her work within the scientific community, and holds an h-index of 12. Dr. Erdoğdu has collaborated with a broad network of 40 international and national co-authors, contributing to interdisciplinary research efforts. Her work supports translational pharmaceutical research with potential societal impact in improving targeted, patient-friendly therapies.

Citation Metrics (Scopus Preview)

538
400
300
150
0

Citations

538

Documents

23

h-index

12

Citations

Documents

h-index

View Scopus Profile
               View ORCID Profile

Top 5 Featured Publications